Gene "MLH1"
Found 1 record
Gene information
Gene symbol:
MLH1
See related:
Ensembl: ENSG00000076242, Gene ID: 4292
Additive variants :
Detected
Genetic interaction partners
Confidence      Stringent (ε>0.16 or ε<-0.12)      Intermediate (-0.16≤ε≤-0.08 or 0.08≤ε≤0.16)      Lenient (|ε|<0.08)
Positive interactions
  • ZFP42 
  • SC5D 
  • ELOVL1 
  • KIAA1109 
  • PSMA4 
  • CS 
  • DLAT 
  • SCPEP1 
  • PBLD 
  • MRS2 
  • PHB2 
  • ELOVL1 
  • MSH2 
  • PSAT1 
  • EDF1 
  • CNIH3 
  • UBC 
  • CNN3 
  • SURF4 
  • PIGG 
  • SLC35B1 
  • BRD1 
  • H3F3C 
  • ANKZF1 
  • TBC1D22A 
  • PDXP 
  • AADAT 
  • SLC3A1 
  • TVP23B 
  • ASNA1 
  • EIF5A2 
  • PPP2R5C 
  • FKBP7 
  • PIAS1 
  • WDR45B 
  • ZFP42 
  • CLN3 
  • ATG3 
  • SRXN1 
  • SUCLG2 
  • MSH6 
  • NMNAT1 
  • OSBP 
  • RPL13A 
  • UBE3C 
  • ARHGAP11A 
  • RPS6KA1 
  • SDHB 
  • CLK2 
  • DNAJA4 
  • TCF25 
  • PPP2CB 
  • ALDH1L2 
  • SLC13A4 
  • LSM1 
  • EPN3 
  • GRK7 
  • PRPSAP2 
  • FIS1 
  • ATP10B 
  • DMXL1 
Negative interactions
  • LIAS 
  • URM1 
  • ATP1A1 
  • TRMT1L 
  • CLIP1 
  • RPS6 
  • ACTR6 
  • ERCC6 
  • RPS24 
  • PIF1 
  • PTRH1 
  • VAC14 
  • RPL7 
  • VAPB 
  • BIN3 
  • MGAM2 
  • CHD8 
  • PDIA5 
  • SMARCB1 
  • CHD1L 
  • ABCC6 
  • ECHDC2 
  • DCUN1D5 
  • SLC13A4 
  • WDHD1 
  • CAMK2D 
  • RPL4 
  • CAPZB 
  • RAB5B 
  • TARBP1 
  • RPEL1 
  • RER1 
  • PPAT 
  • TRIP12 
  • UBE2N 
  • GLIPR2 
  • HAGHL 
  • PPM1L 
  • RNF19A 
  • ALDH16A1 
  • CCNA2 
  • RAB5B 
  • UPF2 
  • XPNPEP3 
  • RANGRF 
  • RPL34 
  • TMEM165 
  • BUD31 
  • ALG8 
  • CERK 
  • SBF1 
  • PEX14 
Modifier statisitcs
Record:
Disorder:
Vriant:
Reference:
Effect type:
Expressivity(1)  
Modifier effect:
Risk factor(1)  
Detail:
  • Variant 1:
    Gene:
    Genomic location:
    chr3:37034946
    dbSNP ID:
    Target disease:
    Colorectal Cancer(DOID_9256)
    Effect type:
    Expressivity 
    Modifier effect:
    Risk factor 
    Evidence:
    From review article 
    Effect:
    Genetic variants identifed using candidate-gene association studies, signifcantly associated with a risk of colorectal cancer in meta-analyses and showing strong and moderate cumulative evidence of association according to Venice criteria and false-positive report probability tests
    Reference:
    Title:
    Genetic predisposition to colorectal cancer: where we stand and future perspectives.
    Species studied:
    Human
    Abstract:
    The development of colorectal cancer (CRC) can be influenced by genetic factors in both familial cases and sporadic cases. Familial CRC has been associated with genetic changes in high-, moderate- and low-penetrance susceptibility genes. However, despite the availability of current gene-identification techniques, the genetic causes of a considerable proportion of hereditary cases remain unknown. Genome-wide association studies of CRC have identified a number of common low-penetrance alleles associated with a slightly increased or decreased risk of CRC. The accumulation of low-risk variants may partly explain the familial risk of CRC, and some of these variants may modify the risk of cancer in patients with mutations in high-penetrance genes. Understanding the predisposition to develop CRC will require investigators to address the following challenges: the identification of genes that cause uncharacterized hereditary cases of CRC such as familial CRC type X and serrated polyposis; the classification of variants of unknown significance in known CRC-predisposing genes; and the identification of additional cancer risk modifiers that can be used to perform risk assessments for individual mutation carriers. We performed a comprehensive review of the genetically characterized and uncharacterized hereditary CRC syndromes and of low- and moderate-penetrance loci and variants identified through genome-wide association studies and candidate-gene approaches. Current challenges and future perspectives in the field of CRC predisposition are also discussed.